Mass General Brigham Research/LinkedIn
May 24, 2026, 00:41
Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
Mass General Brigham Research shared a post on LinkedIn:
“The ASGCT Annual Meeting is the leading conference focused on advancements in gene and cell therapy research, innovation, clinical trials, and scientific discovery.
Earlier this month, several members of the Mass General Brigham Gene and Cell Therapy Institute attended the meeting and connected with attendees at our booth.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH